MLchartDataset catalogue

metabolic anti-cancer agent ASCA101

Term · Oncology and biomedicine · MLC-T-ONC-015115

An agent targeting cancer metabolic processes, with potential antineoplastic activity. Upon administration, metabolic anti-cancer agent ASCA101 may disrupt one or more specific metabolic processes in cancer cells, which may lead to an increase in reactive oxygen species (ROS) and adenosine-5'-triphosphate (ATP) depletion. This causes apoptosis and prevents proliferation of susceptible cancers cells only while sparing normal, healthy cells.

Table 1. Record
IdentifierMLC-T-ONC-015115
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015115",
  "term": "metabolic anti-cancer agent ASCA101",
  "field": "Oncology and biomedicine",
  "definition": "An agent targeting cancer metabolic processes, with potential antineoplastic activity. Upon administration, metabolic anti-cancer agent ASCA101 may disrupt one or more specific metabolic processes in cancer cells, which may lead to an increase in reactive oxygen species (ROS) and adenosine-5'-triphosphate (ATP) depletion. This causes apoptosis and prevents proliferation of susceptible cancers cells only while sparing normal, healthy cells.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/metabolic-anti-cancer-agent-asca101/"
}

Record 10,898 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.